Abbott Laboratories To Go Ex-Dividend On July 15th, 2024 With 0.55 USD Dividend Per Share
June 14th (Eastern Time) - $Abbott Laboratories(ABT.US)$ is trading ex-dividend on July 15th, 2024.Shareholders of record on July 15th, 2024 will receive 0.55 USD dividend per share on August 15th, 20
Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15
12:20 PM EDT, 06/14/2024 (MT Newswires) -- Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15 Price: 103.41, Change: -0.04, Percent
Express News | Abbott - Declared a Quarterly Common Dividend of 55 Cents per Share.
Press Release: Abbott Declares 402nd Consecutive Quarterly Dividend
Abbott Declares 402nd Consecutive Quarterly Dividend PR Newswire ABBOTT PARK, Ill., June 14, 2024 ABBOTT PARK, Ill., June 14, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $140
Barclays analyst Matt Miksic maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $140.According to TipRanks data, the analyst has a success rate of 62.3% and a
Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
Biowearables 101: Health Tech That Goes Deeper
New health wearables give you more options to continuously monitor your glucose levels and understand your body.NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / More and more people, whether they're wee
Overnight News: Apple holds WWDC24 developer conference, French election shakes investor confidence, Musk says he will ban Apple devices from his company.
For more global financial information, please visit the real-time financial news 7x24. Market closing: S&P and Nasdaq hit new highs, market attention to Fed policy meeting. June 10th Top 20 US stocks by turnover: Taiwan Semiconductor plans to raise prices for Nvidia, and the stock price hits a historical high. US WTI crude oil rose 2.9% on Monday, and Goldman Sachs said there will be a shortage of crude oil supply in the next few weeks. June 10th Top 20 US stocks by turnover: Taiwan Semiconductor plans to raise prices for Nvidia, and the stock price hits a historical high. Major European stock market indices fell, and France's CAC40 index fell more than 1%. Macro level: Early French elections shake investors' confidence in the economy.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics 2024-2029, With Profiles of Leading Market Players, Including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global market for polymerase
4 Constructive Medical Devices Stocks - BTIG
Abbott Laboratories's Options: A Look at What the Big Money Is Thinking
Deep-pocketed investors have adopted a bullish approach towards Abbott Laboratories (NYSE:ABT), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga u
Express News | Abbott Plans to Launch Its Device Lingo This Summer - Spokesperson
Express News | Abbott Receives FDA Clearance For Its Lingo And Libre Rio Over-the-Counter Continuous Glucose Monitoring Systems
Express News | Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Wells Fargo analyst Larry Biegelsen maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $133.According to TipRanks data, the analyst has a success rate of 60.1
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
Express News | Abbott Receives Ce Mark for Aveir™ DR, World's First Dual Chamber Leadless Pacemaker System
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
BofA Securities Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
BofA Securities analyst Travis Steed maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $133.According to TipRanks data, the analyst has a success rate of 63.
Abbott (ABT) Stock Dips While Market Gains: Key Facts
No Data